Innovative projects to improve ovarian cancer prevention and treatment
Official title: DRP: Developmental Research Program
Funded at University of Pittsburgh at Pittsburgh · NIH-10925301 · Data updated 2026-11-12
This study is looking for new and creative ways to help prevent and treat ovarian cancer, especially by supporting researchers from diverse backgrounds, so that we can find better ways to detect the disease early and improve outcomes for everyone affected.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pittsburgh at Pittsburgh NIH-funded |
| Lab location | 1 site (Pittsburgh, United States) |
| Project start | September 1, 2023 |
| Project end | August 31, 2028 |
| Funding year | 2024 |
| Award (this year) | $112,687 |
| NIH project number | 5P50CA272218-02 |
| Project ID | NIH-10925301 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include individuals at risk for ovarian cancer or those diagnosed with the disease seeking innovative treatment options.
✕Less likely to help
Patients with cancers other than ovarian cancer may not receive direct benefits from this research.
What this research studies
The Developmental Research Program (DRP) at the UPMC Hillman Cancer Center focuses on funding innovative pilot projects aimed at reducing ovarian cancer morbidity and mortality. This program emphasizes research in prevention, early detection, tumorigenesis mechanisms, therapeutic resistance, and the identification of predictive biomarkers. By supporting underrepresented minorities in ovarian cancer research, the DRP aims to foster diversity and inclusion in scientific inquiry. The program will solicit proposals annually and select the most promising projects through a rigorous review process.
Why it matters
Potential benefit: If successful, this research could lead to improved prevention strategies and treatment options for ovarian cancer patients.
How similar studies have gone: Previous similar initiatives have shown significant success, with a reported 35-fold return on investment from earlier projects.
Where this research is happening
-
University of Pittsburgh at Pittsburgh
Pittsburgh, United States Active
Researchers
- Principal investigator: Olawaiye, Alexander — University of Pittsburgh at Pittsburgh
- Study coordinator: Olawaiye, Alexander
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.